Screening for polygenic conditions and risk scores

Under pressure to help combat this public health crisis, the Food and Drug Administration has begun taking steps intended to reduce overdoses and opioid use disorder, but critics warn against use of controversial DNA test.

Polygenic Risk Prediction in Diverse Populations and Contexts: Scientific and Ethical Considerations

Read more about Polygenic Risk Prediction in Diverse Populations and Contexts: Scientific and Ethical Considerations

This ELSI Friday Forum took place on January 12, 2024.

ELSIcon2022 Paper: Physician Perspectives on Polygenic Risk Scores

Read more about ELSIcon2022 Paper: Physician Perspectives on Polygenic Risk Scores

ELSIcon2022 • Paper • May 27, 2022

Stephanie M. Fullerton, David R. Crosslin, Gail P. Jarvik, Susan Trinidad

ELIScon2022 Panel: Polygenic Embryo Screening: Ethical Considerations and Stakeholder Perspectives

Read more about ELIScon2022 Panel: Polygenic Embryo Screening: Ethical Considerations and Stakeholder Perspectives

ELSIcon2022 • Panel Session 4 • May 31, 2022

Gabriel Lázaro-Muñoz, Stacey Pereira, Todd Lencz, Laura Hercher

ELSIcon2022 Late-Breaking: Laypeople overestimate the predictive power of polygenic scores but do not view them as any more anxiety-producing than other scores for the same trait

Read more about ELSIcon2022 Late-Breaking: Laypeople overestimate the predictive power of polygenic scores but do not view them as any more anxiety-producing than other scores for the same trait

ELSIcon2022 • Networking Session • Late-breaking Abstracts • May 31, 2022

Michelle Meyer

ELSIcon2022 Paper: Child and adolescent psychiatrists’ knowledge, attitudes, and experiences with polygenic risk scores

Read more about ELSIcon2022 Paper: Child and adolescent psychiatrists’ knowledge, attitudes, and experiences with polygenic risk scores

ELSIcon2022 • Paper • June 1, 2022

Stacey Pereira, Katrina Muñoz, Takahiro Soda, Brent Small, Laura Torgerson, Clarissa Sanchez, Jehannine Austin, Eric Storch, Gabriel Lázaro-Muñoz

ELSIcon2022 Paper: Clinician experiences and perspectives on the use of polygenic risk scores in child and adolescent psychiatry

Read more about ELSIcon2022 Paper: Clinician experiences and perspectives on the use of polygenic risk scores in child and adolescent psychiatry

ELSIcon2022 • Paper • June 1, 2022

Gabriel Lázaro-Muñoz, Eric Storch, Stacey Pereira

ELSIcon2022 Paper: Returning Polygenic Risk Scores to Participants in a Pragmatic Clinical Trial of Breast Cancer Screening: Ethical Dilemmas and Participant (mis)Understanding

Read more about ELSIcon2022 Paper: Returning Polygenic Risk Scores to Participants in a Pragmatic Clinical Trial of Breast Cancer Screening: Ethical Dilemmas and Participant (mis)Understanding

ELSIcon2022 • Paper • June 3, 2022

Jennifer James, Leslie Riddle, Mika Caruncho, Barbara Koenig, Galen Joseph

Newsletter